← Back to Clinical Trials
Recruiting NCT07361315

NCT07361315 Development and Online Evaluation of an Online Course for Parasomnias

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07361315
Status Recruiting
Phase
Sponsor University of Manitoba
Condition Sleep Terror
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-11-14
Primary Completion 2026-12-31

Trial Parameters

Condition Sleep Terror
Sponsor University of Manitoba
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-11-14
Completion 2026-12-31
Interventions
Parasomnia EducationSleep Hygiene Control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Parasomnias are unwanted events during sleep. These refer to sleep terrors, sleepwalking, sleep eating, nightmares, and movement during REM sleep. There are few systematic behavioral treatments for these problems and individuals with them often receive little education about self-management. This research examines and evaluates the effectiveness of a 4 week online course providing education and guidance about managing parasomnias. The primary outcomes are improvement in parasomnia frequency and distress. The secondary outcomes are improvements in work and social adjustment, mood, anxiety, stress level, fatigue, sleepiness, insomnia, and cognitive interference.

Eligibility Criteria

Inclusion Criteria: * physician referred for parasomnia * meet criteria for parasomnia on the Structured Clinical Interview for Sleep Disorders (SCISD-R) * age \>= 18 years * parasomnia duration \>= 6 months * English reading, sighted * access to device. Exclusion Criteria: * currently taking one of Lithium, Thioridazine, Chlorpromazine, Perphenazine, Methaqualone, Amitriptyline, Selective Serotonin Re-Uptake Inhibitors, Serotonin and Norepinephrine Re-Uptake inhibitors, or Zopiclone * seizure or major neurological disorder * untreated sleep apnea, restless legs syndrome, or narcolepsy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology